JAK inhibitors: Perspectives in internal medicine.

[JAK inhibitors: Perspectives in internal medicine]. Rev Med Interne. 2019 Nov 04;: Authors: El Jammal T, Gerfaud-Valentin M, Sève P, Jamilloux Y Abstract In the past ten years, the better understanding of the pathophysiological mechanisms underlying inflammatory and autoimmune diseases has led to the emergence of many targeted therapies. Among them, the Janus kinase inhibitors are acting upstream in the inflammatory cascade of several key cytokines in disorders such as rheumatoid arthritis, ulcerative colitis or psoriasis. At the moment, these three diseases represent the only indications validated by the FDA and the EMA of the use of JAK inhibitors apart from hematology. Preclinical data and therapeutic trials indicate their efficacy in other autoimmune or inflammatory conditions, such as lupus, dermatomyositis, ankylosing spondylitis, sarcoidosis and giant cell arteritis. This review provides a summary of current use and advancement of knowledge in the use of JAK inhibitors in pathologies faced by internists. PMID: 31699450 [PubMed - as supplied by publisher]
Source: Revue de Medecine Interne - Category: Internal Medicine Tags: Rev Med Interne Source Type: research

Related Links:

Publication date: Available online 1 August 2020Source: Autoimmunity ReviewsAuthor(s): Arnon Blum, Mohammad Adawi
Source: Autoimmunity Reviews - Category: Allergy & Immunology Source Type: research
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
CONCLUSION: miR-182-5p mimic therapy inhibits the pathogenic Th17 response in EAU mice. miR-182-5p's inhibition of TAF15 negatively regulates Th17 cell development by suppressing STAT3 phosphorylation. As TAF15 shows a positive relationship with Th17 cell markers in uveitis patients, the miR-182-5p/TAF15 axis shows promise as a therapeutic target for uveitis. PMID: 32736708 [PubMed - as supplied by publisher]
Source: Biochemical and Biophysical Research communications - Category: Biochemistry Authors: Tags: Biochem Biophys Res Commun Source Type: research
Publication date: Available online 2 August 2020Source: Joint Bone SpineAuthor(s): Florenzo Iannone, Ennio G Favalli, Roberto Caporali, Salvatore D’Angelo, Francesco Paolo Cantatore, Piercarlo Sarzi-Puttini, Rosario Foti, Fabrizio Conti, Antonio Carletto, Elisa Gremese, Alberto Cauli, Roberta Ramonda, Adalgisa Palermo, Oscar Epis, Marta Priora, Francesca Bergossi, Bruno Frediani, Fausto Salaffi, Giuseppe Lopalco, Fabio Cacciapaglia
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
In this study, we examined the effects of oxytocin on the Aβ-induced impairment of synaptic plasticity in mice. To investigate the effect of oxytocin on synaptic plasticity, we prepared acute hippocampal slices for extracellular recording and assessed long-term potentiation (LTP) with perfusion of the Aβ active fragment (Aβ25-35) in the absence and presence of oxytocin. We found that oxytocin reversed the impairment of LTP induced by Aβ25-35 perfusion in the mouse hippocampus. These effects were blocked by pretreatment with the selective oxytocin receptor antagonist L-368,899. Furthermore, the tr...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
CONCLUSIONS: 1. Good outcomes of single stage revision ACL reconstruction surgery are achievable as de-monstrated in our cohort. 2. There is need for good quality research to identify whether BTB, hamstrings or quadriceps autografts are better for ACL Reconstruction. PMID: 32732443 [PubMed - in process]
Source: Ortopedia Traumatologia Rehabilitacja - Category: Orthopaedics Tags: Ortop Traumatol Rehabil Source Type: research
Purpose of review This review concerns the outcome for nonsystemic juvenile idiopathic arthritis (JIA) with emphasis on treatment-to-target (T2T) and treatment strategies aiming at inactive disease by giving an overview of recent articles. Recent findings More efficacious therapies and treatment strategies/T2T with inactive disease as target, have improved the outcome for JIA significantly. Recent studies regarding treatment strategies have shown 47–68% inactive disease after 1 year. Moreover, probability of attaining inactive disease at least once in the first year seems even higher in recent cohort-studies, re...
Source: Current Opinion in Rheumatology - Category: Rheumatology Tags: PEDIATRIC AND HERITABLE DISORDERS: Edited by Polly J. Ferguson Source Type: research
Purpose of the review To highlight the current challenges in diagnosis and clinical care of pediatric rheumatic disease and barriers to research and education of pediatric rheumatologists worldwide. Recent findings Recent studies and reports demonstrate a paucity of studies on epidemiology, outcomes, and management guidelines from many regions of the world. There have been noteworthy efforts to bridge the gap in under resourced areas. An analysis of the global burden of rheumatic disease has demonstrated that while understudied, musculoskeletal diseases are prevalent and increasingly contribute to loss of years of hea...
Source: Current Opinion in Rheumatology - Category: Rheumatology Tags: PEDIATRIC AND HERITABLE DISORDERS: Edited by Polly J. Ferguson Source Type: research
Publication date: Available online 29 July 2020Source: Journal of EthnopharmacologyAuthor(s): Le Kuai, Jiankun Song, Ruoxi Zhang, Meng Xing, Ying Luo, Yi Ru, Xiao-jie Ding, Liu Liu, Yi Lu, Xiaoying Sun, Hua Nian, Xin Li, Bin Li
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
Roberta Cassano Psoriasis is one of the most common human skin disorders. Although its pathogenesis is complex and not completely know, the hyperactivation of the immune system seem to have a key role. In this regard, among the most effective systemic therapeutics used in psoriasis, we find cyclosporine, an immunosuppressive medication. However, one of the major problems associated with the use of cyclosporine is the occurrence of systemic side effects such as nephrotoxicity, hypertension, etc. The present work fits in this context and its aim is the design of suitable platforms for cyclosporine topical release in pso...
Source: Molecules - Category: Chemistry Authors: Tags: Article Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Autoimmune Disease | Dermatology | Dermatomyositis | Hematology | Inflammatory Bowel Disease | Internal Medicine | Lupus | Psoriasis | Rheumatoid Arthritis | Rheumatology | Sarcoidosis | Ulcerative Colitis